Matthew Richard Moore, SVP and Chief Business Officer: Arcutis Biotherapeutics ARQT Sell · Filed 24/05/03

Trade details

Type: Insider sale
Amount: $40,911.94
Shares · price: 4,681 sh · $8.74 a share
Held after: 145,505 sh
Stock: Arcutis Biotherapeutics ARQT
Person: Matthew Richard MooreSVP and Chief Business Officer
Trade date: 24/05/02
Filed: 24/05/03
Days to filing: 1 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

Arcutis Biotherapeutics trades, last 26 weeks

What else happened in Arcutis Biotherapeutics around then

Filed or reported within 30 days of the trade day · 24/04/02~24/06/01

Matthew Richard Moore's recent trades

Matthew Richard MooreSVP and Chief Business Officer
Sell10b5-1 planArcutis Biotherapeutics
Sell10b5-1 plan
Arcutis Biotherapeutics
ARQT
$38.6K
3,468 sh
$38.6K
Filed 24/03/06
Traded 24/03/04
Matthew Richard MooreSEE REMARKS
SellArcutis Biotherapeutics
Sell
Arcutis Biotherapeutics
ARQT
$25.1K
1,589 sh
$25.1K
Filed 23/03/06
Traded 23/03/02
Matthew Richard MooreSEE REMARKS
SellArcutis Biotherapeutics
Sell
Arcutis Biotherapeutics
ARQT
$347
21 sh
$347
Filed 23/03/06
Traded 23/03/02